Types, Effects, Risks, and Legal Status of Psychoactive Substances in Canada
Last reviewed: September 2026
Psychoactive substances are chemicals that affect the brain and nervous system, producing changes in mood, perception, consciousness, cognition, behaviour, or physical functioning. They include everyday substances such as caffeine and nicotine, prescription medicines, legal cannabis, alcohol, and substances controlled or prohibited under Canadian law.
Because Psychoactive substances in Canada encompass such a broad range of compounds, it is misleading to describe them all as “drugs” in the same way. Their effects, medical uses, dependence potential, health risks, and legal status can be dramatically different.
In Canada, some psychoactive substances are legally available to adults, some require a prescription, some are controlled for medical and scientific purposes, and others are prohibited outside specific authorized circumstances.
Pharma Nexus explains the major categories of psychoactive substances encountered in Canada, how they affect the body, the risks associated with their use, and how Canadian law approaches different substances.
What Are Psychoactive Substances?
A psychoactive substance is a chemical that changes activity within the central nervous system and consequently affects mental processes or behaviour.
Depending on the substance, these changes can include:
- increased alertness;
- relaxation;
- sedation;
- euphoria;
- altered perception;
- changes in mood;
- increased energy;
- reduced anxiety;
- impaired coordination;
- changes in memory;
- hallucinations;
- altered consciousness.
Psychoactive substances can be natural, semi-synthetic, or fully synthetic.
They can also be administered in many pharmaceutical or non-medical forms, including tablets, capsules, liquids, inhaled substances, or other preparations.
The fact that a substance is psychoactive does not, by itself, determine whether it is legal, medically useful, dangerous, addictive, or controlled.
Psychoactive Substances and Canadian Law
Canadian law does not classify every psychoactive substance in a single legal category.
Different substances are governed by different federal and provincial or territorial frameworks.
The Controlled Drugs and Substances Act (CDSA) is the principal federal statute controlling many substances considered to present significant risks to health or society.
The CDSA establishes schedules and offences involving activities such as unauthorized possession, trafficking, production, importation, and exportation.
However, some psychoactive substances have separate regulatory frameworks.
The clearest example is cannabis, which is regulated federally under the Cannabis Act and associated regulations.
Prescription medicines are also governed through Canada’s broader pharmaceutical and healthcare regulatory system.
Consequently, the terms psychoactive, controlled, prescription, and illegal are not interchangeable.
Major Categories of Psychoactive Substances
Psychoactive substances can be classified according to their primary effects on the central nervous system. These pharmacological categories are useful for understanding effects and risks, but they do not necessarily correspond to Canada’s legal schedules.
Depressants and Sedatives
Depressants reduce activity within parts of the central nervous system.
They can cause:
- relaxation;
- drowsiness;
- reduced anxiety;
- impaired coordination;
- slowed reaction time;
- decreased alertness.
Examples include certain benzodiazepines, barbiturates, and other sedative medications. Alcohol is also a central nervous system depressant, although its legal framework differs from that of controlled substances under the CDSA.
Health risks
Excessive exposure to depressants can cause:
- extreme sedation;
- confusion;
- loss of consciousness;
- impaired breathing;
- accidents and injuries;
- dependence;
- withdrawal.
Combining depressants can significantly increase risk. Of particular concern is the combination of opioids with other central nervous system depressants, including alcohol and certain sedative medications.
Opioids
Opioids are substances that act primarily on opioid receptors in the nervous system. They include medicines such as:
as well as illicit opioids such as heroin. Opioids can have legitimate medical uses, particularly for pain management and certain forms of substance-use treatment.
Effects
Common effects can include:
- pain relief;
- sedation;
- relaxation;
- euphoria;
- drowsiness.
Risks
The most serious acute risk is respiratory depression, in which breathing becomes dangerously slow or stops. Other risks include:
- tolerance;
- physical dependence;
- opioid use disorder;
- constipation;
- sedation;
- overdose.
Illicit opioid products create additional concerns because their contents and potency may be unpredictable. Fentanyl is particularly significant in Canada’s public-health context because of its extreme potency and the presence of illicit fentanyl in the unregulated drug supply.
Stimulants
Stimulants increase activity within the central nervous system. Examples include:
- cocaine;
- methamphetamine;
- amphetamine;
- methylphenidate;
- certain prescription ADHD medications.
Stimulants can increase:
- alertness;
- attention;
- energy;
- heart rate;
- blood pressure.
Prescription stimulants such as methylphenidate and amphetamine can have legitimate medical applications when appropriately prescribed and monitored.
Risks
Potential adverse effects include:
- anxiety;
- insomnia;
- increased blood pressure;
- rapid heart rate;
- agitation;
- cardiovascular complications;
- paranoia;
- psychosis;
- dependence or substance-use disorder.
Risk depends on the substance, formulation, dose, route of administration, frequency of exposure, and individual health factors.
Cannabis
Cannabis contains numerous cannabinoids, with THC (tetrahydrocannabinol) being the primary intoxicating cannabinoid. Cannabis can affect:
- mood;
- perception;
- memory;
- attention;
- coordination;
- reaction time.
Canada has a distinct legal framework for cannabis under the Cannabis Act. Adults who meet applicable federal and provincial or territorial requirements can legally possess and purchase cannabis online through authorized systems.
However, cannabis legalization does not mean cannabis is risk-free. Potential health concerns include:
- impaired driving;
- impaired coordination;
- anxiety or panic;
- dependence;
- cognitive effects;
- psychotic symptoms in susceptible individuals.
Risk varies according to factors including age, frequency of use, THC concentration, individual vulnerability, and method of consumption.
Psychedelics
Psychedelics are substances capable of substantially altering perception, cognition, mood, and consciousness. Examples include:
Effects can include:
- visual or sensory changes;
- altered perception of time;
- intensified emotions;
- unusual thought patterns;
- hallucinations.
Risks
Psychedelic experiences can sometimes become psychologically distressing. Potential problems include:
- panic;
- anxiety;
- paranoia;
- confusion;
- impaired judgment;
- accidents;
- persistent psychological symptoms in vulnerable individuals.
Legal status varies by substance. Many classic psychedelic substances are controlled under Canadian federal law, while scientific and medical research involving certain compounds may occur under authorized conditions.
Dissociatives
Dissociatives can produce feelings of detachment from the body or surroundings and can significantly alter perception.
Ketamine is an important example. It has legitimate medical applications as an anesthetic and is also used in some specialized medical contexts.
Other dissociative substances can be controlled under Canadian law. Potential effects include:
- altered perception;
- detachment;
- confusion;
- impaired coordination;
- changes in sensory processing.
Repeated or heavy use of some dissociatives can cause significant physical or psychological problems.
Benzodiazepines
Benzodiazepines are prescription medicines that generally produce sedative, anxiolytic, anticonvulsant, and muscle-relaxant effects. Examples include:
- diazepam;
- lorazepam;
- clonazepam;
- alprazolam.
They can be useful in appropriate medical circumstances, but prolonged or inappropriate use can lead to:
- tolerance;
- physical dependence;
- sedation;
- impaired memory;
- impaired coordination;
- withdrawal.
Combining benzodiazepines with opioids or alcohol can increase the risk of severe sedation and respiratory depression. Abruptly stopping some benzodiazepines after prolonged use can also cause serious withdrawal symptoms. Medical supervision may therefore be appropriate when discontinuing long-term treatment.
Empathogens and Entactogens
MDMA is commonly classified as an empathogen or entactogen. It can produce changes in:
- mood;
- emotional openness;
- sensory perception;
- energy;
- sociability.
However, MDMA can also increase heart rate and body temperature and may cause dehydration or other physiological complications. Illicit products sold as MDMA may contain different substances, creating additional uncertainty.
Inhalants
Inhalants are chemicals whose vapours can produce psychoactive effects when inhaled. They may include certain:
- solvents;
- gases;
- aerosols;
- industrial chemicals.
Inhalant exposure can affect the brain, heart, lungs, liver, kidneys, and other organs. Severe poisoning can result in loss of consciousness, seizures, cardiac complications, or death. Because many inhalants are ordinary commercial or household chemicals, the fact that a product is legally sold does not make intentional inhalation safe.
Nicotine
Nicotine is a psychoactive stimulant found naturally in tobacco and used in various nicotine-containing products.
It can increase alertness and produce short-term changes in mood and concentration. Nicotine has a particularly strong potential for dependence.
Long-term tobacco use is associated with major health risks, including cardiovascular disease, respiratory disease, and cancer. Canada regulates tobacco and nicotine products through specific federal and provincial frameworks rather than treating them simply as CDSA-controlled substances.
Caffeine
Caffeine is one of the world’s most widely used psychoactive substances. It is found in products including:
- coffee;
- tea;
- energy drinks;
- some medications;
- chocolate.
Caffeine is a stimulant that can increase alertness and reduce perceived fatigue. High intake can contribute to:
- anxiety;
- insomnia;
- restlessness;
- rapid heartbeat;
- gastrointestinal symptoms.
Regular caffeine use can also produce physical dependence, with headaches, fatigue, and irritability sometimes occurring after abrupt reduction
Psychoactive Substances and Dependence
Not every psychoactive substance produces dependence in the same way. Dependence can be:
Physical: the body adapts to repeated exposure, producing withdrawal when the substance is reduced or stopped.
Psychological: a person experiences cravings or feels that they need a substance to function or feel normal.
Substance use disorder is a broader clinical condition involving impaired control over substance use and continued use despite significant consequences. Risk depends on numerous factors, including:
- pharmacology;
- potency;
- frequency of use;
- duration;
- route of administration;
- individual vulnerability;
- mental health;
- other substances being used.
A person can also become physically dependent on certain prescribed medicines without developing an addiction
Withdrawal
Withdrawal varies considerably between substances. Opioid withdrawal can involve:
- muscle aches;
- sweating;
- nausea;
- diarrhea;
- anxiety;
- restlessness;
- cravings.
Sedative and benzodiazepine withdrawal can involve anxiety, insomnia, agitation, and, in severe cases, seizures or other serious complications. Stimulant withdrawal may involve:
- fatigue;
- low mood;
- increased sleep;
- irritability;
- cravings.
Because withdrawal can occasionally be dangerous, particularly with certain depressants, people should seek professional medical guidance when stopping substances after prolonged or heavy use.
Overdose and Poisoning
Overdose occurs when the body’s exposure to a substance exceeds its ability to respond safely. Different categories produce different overdose patterns.
Opioids
The primary life-threatening effect is respiratory depression. Warning signs can include:
- inability to wake;
- very slow or absent breathing;
- unusual snoring or gurgling;
- blue, grey, or pale lips or skin.
Call 911 immediately if an opioid overdose is suspected. Naloxone should be administered if available.
Stimulants
Severe stimulant toxicity can involve:
- chest pain;
- seizures;
- extreme agitation;
- dangerously high body temperature;
- severe confusion;
- cardiovascular complications.
Depressants
Severe depressant poisoning can cause:
- profound sedation;
- unconsciousness;
- slowed breathing;
- loss of protective reflexes.
Mixed-substance exposure can substantially increase danger.
Harm Reduction in Canada
Harm reduction refers to measures intended to reduce the health and social consequences associated with substance use.
Canadian harm-reduction approaches can include:
- naloxone distribution;
- overdose education;
- drug-checking services where available;
- supervised consumption and related health services where available;
- safer-use education;
- treatment and recovery services;
- infectious-disease prevention;
- connections to healthcare.
Harm reduction does not require someone to stop using substances before they can receive support. Canada’s Canadian Drugs and Substances Strategy incorporates prevention, substance-use services and supports, evidence, and substance controls as interconnected components of the national approach.
Psychoactive substance risks and Canada’s Illicit Drug Supply
One of the most significant public-health concerns is that illicit products may not contain what their names or packaging suggest.Counterfeit tablets and illicit powders can contain unexpected substances or combinations.
This creates particular risks with highly potent opioids such as fentanyl. A street name, logo, colour, tablet shape, or seller’s description cannot reliably establish the chemical composition of an illicit product. Where substance composition is uncertain, the risk can be substantially greater than the expected pharmacological profile suggests.
Psychoactive substances legal status Canada
Legal status should always be assessed separately from pharmacology.
A substance can be:
Legal and widely available
Examples include caffeine and nicotine products, subject to applicable regulations.
Legal but regulated
Cannabis is an important example, with federal and provincial or territorial restrictions.
Prescription-only
Certain psychoactive medicines require authorization from a healthcare professional.
Controlled
Certain substances are regulated under the CDSA and related regulations but can have legitimate medical, scientific, or other authorized uses.
Prohibited outside specific authorized circumstances
Many illicit-market substances fall into this category.
The legal status of an individual substance can change through legislative and regulatory amendments, so current official Canadian sources should be consulted for definitive information.
Research Chemicals and Novel Psychoactive Substances
“Research chemical” is a broad marketing or descriptive term rather than a guarantee of legal status.
A substance described as a research chemical may still be controlled under Canadian law. Some compounds may also fall within provisions concerning analogues, derivatives, isomers, or salts.
This is particularly important when evaluating unfamiliar psychoactive compounds marketed online. A label such as “for research use only” does not by itself establish that possession, sale, importation, or human use is lawful.
How to Evaluate Information About a Psychoactive Substance
When researching any psychoactive substance, consider five questions:
What is the substance?
Identify the precise chemical or pharmaceutical name.
How does it work?
Understand its pharmacological mechanisms and major effects on the body.
What are the health risks?
Consider acute toxicity, interactions, dependence, withdrawal, and long-term risks.
What is its Canadian legal status?
Check the current federal schedules and applicable regulations, as well as provincial or territorial requirements where relevant.
Is the product composition known?
A regulated pharmaceutical product and an illicit-market product bearing the same name may present very different risks.
Frequently Asked Questions
What are psychoactive drugs Canada?
Psychoactive substances are chemicals that affect the brain and nervous system, changing mood, perception, cognition, consciousness, or behaviour.
Are all types of psychoactive substances illegal?
No. Caffeine, nicotine, alcohol, prescription medicines, and legally regulated cannabis are examples of psychoactive substances that are available within different legal frameworks.
Are psychoactive drugs and their effects the same as controlled substances?
No. “Psychoactive” describes an effect on the nervous system, while “controlled substance” refers to a legal and regulatory category.
Is cannabis a controlled psychoactive substances Canada?
Yes. THC and other cannabinoids can affect mood, perception, cognition, and coordination.
Are prescription drugs psychoactive on Canadian drug information?
Some are. Many prescription medicines act on the central nervous system and can alter mood, alertness, perception, pain, or other neurological functions.
What psychoactive substances and addiction have the greatest overdose risk?
Risk depends on the substance, exposure, formulation, interactions, and individual circumstances. Opioids are particularly associated with potentially fatal respiratory depression, while combinations of depressants can also be extremely dangerous.
Can psychoactive drug effects cause dependence?
Yes. Dependence potential varies substantially between substances.
Is “research chemical” a legal category in Canada?
No. The phrase does not automatically exempt a substance from Canadian drug-control laws.
What should I do if someone appears to be overdosing?
Call 911 immediately. If opioid overdose is suspected and naloxone is available, administer it and follow emergency medical instructions.
Final Takeaway
Psychoactive substances in Canada encompass an enormous range of chemicals, from everyday stimulants such as caffeine to prescription medicines, cannabis, opioids, stimulants, psychedelics, sedatives, and other controlled substances.
Their effects and risks cannot be understood simply by asking whether a substance is “legal” or “illegal.” A complete understanding requires looking at pharmacology, medical use, dependence potential, toxicity, product composition, public-health risks, and Canadian law separately.
The same substance may have an important therapeutic role when appropriately prescribed while presenting serious risks when misused or obtained through an unregulated supply. For consumers and readers, the most important principles are:
Know the substance.
Understand what it is and how it affects the body.
Know the risks.
Consider overdose, dependence, interactions, and long-term health effects.
Know the source.
Illicit products may contain unexpected substances.
Know the law.
Canadian legal status depends on the specific substance and circumstances.
Know when to seek help.
Suspected overdose or severe poisoning is a medical emergency. Call 911 and administer naloxone when opioid overdose is suspected and naloxone is available.
Pharma Nexus provides evidence-based information to help understand psychoactive substances from scientific, medical, public-health, and legal perspectives.

